Next Article in Journal
Interleukin-26 is Associated with the Level of Systemic Inflammation and Lung Functions in Obese and Non-obese Moderate-to-Severe Asthmatic Patients
Previous Article in Journal
The Effect of Albuterol with Heliox versus Albuterol Nebulization in Acute Asthma Exacerbation: A Randomized Controlled Clinical Trial
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 90
Issue 1
10.5603/ARM.a2022.0005
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Steroids in COVID-19: Tailor-Made or “One Size Fits All”?

by
Ayush Goel
and
Animesh Ray
*
All India Institute of Medical Sciences, Delhi, India
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2022, 90(1), 94-96; https://doi.org/10.5603/ARM.a2022.0005
Submission received: 30 June 2021 / Revised: 14 August 2021 / Accepted: 14 August 2021 / Published: 27 January 2022

Abstract

Since the RECOVERY trial, steroids have endorsed by all Guideliness for treating moderate-severe COVID-19. The prescribed dose is 6mg dexamethasone or its equivalents for 10 days. However, in clinical practice, there are numerous occasions where the role of steroids cannot be extrapolated from current evidence: patients on immunosuppression, patients with persistent oxygen requirement after ten days of therapy, etc. We highlight the existing caveats and the need for further research and discussion.
Keywords: coronavirus disease 2019; COVID-19; steroids coronavirus disease 2019; COVID-19; steroids

Share and Cite

MDPI and ACS Style

Goel, A.; Ray, A. Steroids in COVID-19: Tailor-Made or “One Size Fits All”? Adv. Respir. Med. 2022, 90, 94-96. https://doi.org/10.5603/ARM.a2022.0005

AMA Style

Goel A, Ray A. Steroids in COVID-19: Tailor-Made or “One Size Fits All”? Advances in Respiratory Medicine. 2022; 90(1):94-96. https://doi.org/10.5603/ARM.a2022.0005

Chicago/Turabian Style

Goel, Ayush, and Animesh Ray. 2022. "Steroids in COVID-19: Tailor-Made or “One Size Fits All”?" Advances in Respiratory Medicine 90, no. 1: 94-96. https://doi.org/10.5603/ARM.a2022.0005

APA Style

Goel, A., & Ray, A. (2022). Steroids in COVID-19: Tailor-Made or “One Size Fits All”? Advances in Respiratory Medicine, 90(1), 94-96. https://doi.org/10.5603/ARM.a2022.0005

Article Metrics

Back to TopTop